by Team Small News | Oct 11, 2025 | Natco, Pharma
India’s Natco Pharma has announced a significant investment in South Africa’s 135-year-old pharmaceutical giant, Adcock Ingram. The R 4.2-billion deal will see Adcock Ingram become a privately-held entity co-owned by Natco and Bidvest, with Bidvest... by Team Small News | Sep 26, 2025 | Natco, Pharma
Natco Pharma, a generic drugmaker, is considering spinning off its agro business into a separate entity. The company’s board of directors has given in-principle approval for the demerger, which is expected to unlock value in the core pharmaceuticals business and... by Team Small News | Sep 25, 2025 | Natco, Pharma
Rajiv Nannapaneni, CEO of Natco Pharma, believes that the Indian pharma sector is not threatened by the recent US trade tariffs. He attributes this to the fact that the US consumes 92% of Indian generic drugs, making it reliant on Indian pharmaceuticals. Nannapaneni... by Team Small News | Sep 4, 2025 | Natco, Pharma
A patent battle is unfolding in India between Danish pharmaceutical company Novo Nordisk and Indian pharmaceutical companies, particularly Hyderabad-based Natco Pharma. The dispute centers around Novo Nordisk’s blockbuster weight-loss drug, semaglutide, which is... by Team Small News | Aug 23, 2025 | Natco, Pharma
Natco Pharma, an Indian pharmaceutical company, has filed a lawsuit against Novo Nordisk, a Danish multinational pharmaceutical company, in a Delhi court over intellectual property rights related to semaglutide. Semaglutide is a medication used to treat type 2... by Team Small News | Aug 2, 2025 | Natco, Pharma
Natco Pharma, a leading pharmaceutical company, has announced the appointment of TC Mallikarjun as Vice President – Quality Control (QC) at its Kothur Pharma Division. This appointment is a significant development for the company, as it continues to strengthen...